Yibing Wu
Executive Director
pharmaceutical
Beta Technologies Inc
China
Biography
Mr. Yibing Wu serves as Non-Executive Director of the Company. Mr. Wu has worked in the following companies: Since November 2015, he has been serving as a director of Summer Bloom Investments Pte. Ltd. Since October 2013, he has been working with Temasek International Pte. Ltd. and is currently the joint head of Portfolio Strategy and Risk Group and the joint head of China. From April 2011 to April 2014, he served as a director of Neptune Orient Lines Limited, a company listed on the Singapore Exchange Limited (stock code: RE2). From September 1996 to August 2008, he worked with McKinsey & Company, where he was a senior partner, the head of Asia Pacific M&A practice and general manager of Beijing office. Mr. Wu obtained a bachelor’s degree in molecular biology from University of Science and Technology of China in the PRC in July 1989 and a Ph.D. degree in biochemistry and molecular biology from Harvard University in the United States in June 1996.
Research Interest
Pharmaceutical science
